Delay in surgery and overall survival in patients with T2 renal masses

In a recent study of 11,848 patients who had surgery for stage T2 renal cell carcinoma (RCC), the researchers looked at the effect of a delay in having surgery on overall survival. The data were taken from the National Cancer Database. The study showed that patients who had a delay of 5 to 6 months […]

read more

IKCS 2020: Treatment selection in kidney cancer

During this interview, Dr Rana McKay from the University of California in San Diego gives a succinct overview of the 19th Annual Meeting of the International Kidney Cancer Symposium (IKCS 2020), including highlights from the meeting. She also discussed the effects of delaying surgery for patients with low stage (T1 and T2) renal cell carcinoma […]

read more

Surgical delay and survival in patients with T2 kidney tumours

This was a retrospective analysis of 11,848 patients who had surgery for a stage T2 renal mass. The researchers looked at the effect of a delay in surgery on overall survival. This study was conducted before the coronavirus pandemic between 2004 and 2015. A delay in surgery between 5 to 6 months resulted in worse […]

read more

Impact of delay in surgery or time to surgery on kidney cancer outcomes

A recent study published in the Journal of Urology this month looked at the waiting times from diagnosis to surgery and the impact this had on outcomes for kidney cancer patients. The time from diagnosis of a kidney tumour to removal of the tumour during surgery can be very worrying for patients and clinicians due […]

read more

Surgical treatment of inferior vena cava tumour thrombi in kidney cancer

The formation of a cancerous blood clot, or thrombus, in one of the main veins that transport blood from the body to the heart, the inferior vena cava, can be a complication in patients with renal cell carcinoma (RCC), occurring in 5-15% of cases. A recent study investigated the surgical treatment of kidney cancer patients […]

read more

Clinical impact of COVID-19 on people with cancer

A recent publication in The Lancet looked at the effect of COVID-19 on the treatment of people with cancer. Data from cancer patients living in the USA, Canada and Spain who were infected with coronavirus were analysed. Nine hundred and twenty eight (928) people with an active or previous cancer and confirmed severe acute respiratory […]

read more

IKCS 2019: Management of small renal masses

In this video interview, Dr Eric Singer from Rutgers Cancer Institute of New Jersey, USA discusses the management of small renal masses at the International Kidney Cancer Symposium (IKCS) in Miami earlier this month. Watch the video interview on Oncology Tube here

read more

ASCO 2019: Immunotherapy before surgery for treating metastatic kidney cancer

The results of this open-label pilot study were presented at the American Society of Clinical Oncology (ASCO) 2019 annual meeting in Chicago earlier this week. The study investigated the use of neoadjuvant (before surgery) immunotherapy in patients with metastatic renal cell carcinoma (RCC). One hundred and five patients with metastatic RCC were randomised to receive […]

read more

Kidney cancer experts talk about the latest advances in treatments

The following interviews with kidney cancer experts discuss the latest advances in the treatment of renal cell carcinoma (RCC) and renal masses: No OS signal in axitinib + avelumab combination therapy – Dr Toni Choueiri, Dana Faber Cancer Institute, Boston, USA Treating renal masses with minimal invasive ablative technique – Dr Alessandro Volpe, Maggiore Della […]

read more
Showing 1 to 10 of 25 results
  TOP